Type I Angiotensin II Receptor Blockade Reduces Uremia‐Induced Deterioration of Bone Material Properties

Chronic kidney disease (CKD) is associated with a high incidence of fractures. However, the pathophysiology of this disease is not fully understood, and limited therapeutic interventions are available. This study aimed to determine the impact of type 1 angiotensin II receptor blockade (AT‐1RB) on pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakamatsu, Takuya, Iwasaki, Yoshiko, Yamamoto, Suguru, Matsuo, Koji, Goto, Shin, Narita, Ichiei, Kazama, Junichiro J, Tanaka, Kennichi, Ito, Akemi, Ozasa, Ryosuke, Nakano, Takayoshi, Miyakoshi, Chisato, Onishi, Yoshihiro, Fukuma, Shingo, Fukuhara, Shunichi, Yamato, Hideyuki, Fukagawa, Masafumi, Akizawa, Tadao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328427/
https://www.ncbi.nlm.nih.gov/pubmed/32786093
http://dx.doi.org/10.1002/jbmr.4159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328427/
https://www.ncbi.nlm.nih.gov/pubmed/32786093
http://dx.doi.org/10.1002/jbmr.4159

Ejemplares similares